PHARMACEUTICAL USES OF CYCLODEXTRINS AND DERIVATIVES

被引:131
作者
DUCHENE, D
WOUESSIDJEWE, D
机构
[1] Laboratoire de Pharmacie Galénique et Biopharmacie URA CNRS 1218, Université de Paris-Sud (Paris XI), Malabry
关键词
D O I
10.3109/03639049009058543
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Due to their particular conformation, cyclodextrins have the remarkable characteristic of being able to include various kinds of molecule inside their hydrophobic cavity, conferring on them an environmental hydrophily. These inclusion compounds have completely new pharmacotechnical properties, but the most important ones concern increases in water solubility and bioavailability. When administered orally, the inclusion compounds decompose, allowing the free active ingredient to be absorbed by the gastro-intestinal mucosa. However, a certain proportion of inclusion compound is absorbed without any dissociation. Some cyclodextrin derivatives are very interesting because of their very high water solubility, and also because of their low parenteral toxicity compared with the original βcyclodextrin. However, in parenteral administration, it is absolutely necessary to study the pharmacokinetic and pharmacological characteristics of the inclusion compound, which must be considered as the true active ingredient. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:2487 / 2499
页数:13
相关论文
共 51 条
[1]   SYNTHESIS OF BRANCHED CYCLOMALTOOLIGOSACCHARIDES USING PSEUDOMONAS ISOAMYLASE [J].
ABE, JI ;
MIZOWAKI, N ;
HIZUKURI, S ;
KOIZUMI, K ;
UTAMURA, T .
CARBOHYDRATE RESEARCH, 1986, 154 :81-92
[2]  
AMDIDOUCHE D, 1989, INT J PHARM, V54, P175
[3]  
Andersen F.M., 1982, ARCH PHARM CHEMI SCI, V10, P80
[4]  
ANDERSEN FM, 1983, ARCH PHARM CHEMI SCI, V11, P66
[5]   EFFECT OF CYCLODEXTRINS ON ANTHRACYCLINE STABILITY IN ACIDIC AQUEOUS-MEDIA [J].
BEKERS, O ;
BEIJNEN, JH ;
BRAMEL, EHG ;
OTAGIRI, M ;
UNDERBERG, WJM .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1988, 10 (05) :207-212
[6]   MECHANISM OF DRUG DISSOLUTION RATE ENHANCEMENT FROM BETA-CYCLODEXTRIN-DRUG SYSTEMS [J].
CORRIGAN, OI ;
STANLEY, CT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :621-626
[7]   CYCLODEXTRINS, THEIR VALUE IN PHARMACEUTICAL TECHNOLOGY [J].
DUCHENE, D ;
VAUTION, C ;
GLOMOT, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (11-13) :2193-2215
[8]  
Duchene D., 1985, STP PHARMA, V1, P323
[9]  
Duchene D., 1985, STP PHARM, V1, P37
[10]  
DUCHENE D, 1990, IN PRESS PHARM TECHN